Effects of Heat and Exercise on the Elimination of Pralidoxime Chloride in Man

Pralidoxime chloride, used clinically to reactive cholinesterase in organophosphate poisoning, is rapidly eliminated by the kidney. In these studies, heat and exercise stress significantly decreased the renal excretion of both pralidoxime and p-aminohippurate (PAH, used to estimate renal plasma flow...

Full description

Saved in:
Bibliographic Details
Main Authors: Swartz,Richard D, Sidell,Frederick R, Burkhardt,Barry H
Format: Report
Language:English
Subjects:
BLOOD PLASMA
CHOLINESTERASE REACTIVATORS
DISTRIBUTION
DRUGS
EXCRETION
EXERCISE(PHYSIOLOGY)
HEAT
METABOLISM
PARASYMPATHOMIMETIC AGENTS
Pharmacology
PYRIDINE ALDOXIME METHOCHLORIDE
TISSUES(BIOLOGY)
URINE
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pralidoxime chloride, used clinically to reactive cholinesterase in organophosphate poisoning, is rapidly eliminated by the kidney. In these studies, heat and exercise stress significantly decreased the renal excretion of both pralidoxime and p-aminohippurate (PAH, used to estimate renal plasma flow) in man. Pharmacokinetic data suggest that overall drug removal from plasma is also affected by changes in tissue distribution of these drugs: with stress conditions there is a marked increase in volumes of drug distribution. Furthermore, decreased total recovery of drugs in the urine under heat and exercise conditions implicates tissue metabolism as a factor of heretofore undetermined significance in the overall elimination of both pralidoxime and PAH. (Author)